Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if cannabis-based medicine compared to a dummy
medicine (placebo that contains no active ingredient) can help the central neuropathic pain
patients experience as a result of multiple sclerosis. This type of pain "central neuropathic
pain" is described as shooting, stabbing, burning or searing like sensation, which is often
worse at night.